Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Wednesday, December 5, 2012
Tuesday, December 4, 2012
Michigan News Briefs: Hune renews call to suspend pharmacy's license
1:36 AM, Dec. 4, 2012'
State Sen. Joe Hune, R-Hamburg Township, on Monday renewed his call for suspending the Michigan license of a Massachusetts compounding pharmacy linked to a national fungal meningitis outbreak.
Hune, for a second time, called on the Michigan Department of Community Health to suspend New England Compounding Center's Michigan license following news of 10 more Michigan cases of meningitis-related infections linked to contaminated steroids produced at the facility.
"I once again demand
the license be revoked. I would like to see the de-partment investigate this wrongdoing so we can prosecute to the fullest extent of the law," Hune said in a statement.
the license be revoked. I would like to see the de-partment investigate this wrongdoing so we can prosecute to the fullest extent of the law," Hune said in a statement.
The department on Monday announced that there are 201 cases and 13 deaths in Michigan tied to the infections, The Associated Press reported.
Additional cases of infection were announced Monday afternoon, bringing the state total up from 188 infections in a count last week.
Four of the deaths were of Livingston County residents, the state reported. Three of the Michigan deaths are being counted
as Indiana cases because that is where treatment occurred in those cases.
as Indiana cases because that is where treatment occurred in those cases.
Hune in recent weeks first called for suspending the Massachusetts company's Michigan license. An October order of summary suspension filed by Gov. Rick Snyder and Attorney General Bill Schuette awaits the signature of the state Bureau of Health Professions director.
If signed, the order will suspend the New England Compounding Center's Michigan license and force the company to cease its operations in Michigan, Hune said.
Continue reading here
Pharmacist’s Corresponding Responsibility
The responsibility for the proper prescribing and
dispensing of medications lies primarily with the
prescribing practitioner. However, a corresponding
responsibility rests with the pharmacist who fills
a prescription order. The DEA recommends that a
pharmacist scrutinize each prescription. Some things to
look for are quantities, directions, or dosages that differ
from usual medical usage or practice. Check to see if the
prescription has been presented in a reasonable length
of time since the prescriber wrote it. If the patient is
returning too frequently or refilling the same prescription
on a weekly or even a daily basis, it may be fraudulent.
To prevent diversion, know the patient and his or her
medication history. Get to know your prescribers and
their signatures and DEA registration numbers. If you
see anything that is suspicious, call the prescriber using
the telephone book or your record of his or her telephone
number and not the number on the prescription for
verification or clarification. If you believe that you have
received a forged, altered, or counterfeit prescription, do
not dispense it. Call your local police department.
Source found here
Office Use in Kansas
Office Use Prescriptions
The Board has been asked on occasion whether
an “office use” prescription is valid. The answer is
no. Medications prescribed must be dispensed to a
patient. When medication is sent from a pharmacy to a
practitioner for administration, the transfer is considered
a distribution.
The transfer of a prescription medication is permitted
from one pharmacy to another pharmacy or practitioner.
The transfer must be documented with an invoice record.
The invoice record must have the name, strength, form of
the medication, the name and address of both the seller
and the purchaser, and the date of the sale. This record
should be maintained for five years with your pharmacy
records.
If the transfer is a controlled substance, the invoice
must also include the DEA number of both the seller
and the purchaser. If the medication is a Schedule II
medication, the purchaser must provide a DEA Form 222
to the seller before the transfer is completed.
A retail pharmacy may transfer prescription drugs to
another retail pharmacy to alleviate a temporary shortage,
except that the gross dollar value of these transfers
shall not exceed 5% of the total prescription-only drug
sales revenue of either the transferor or the transferee
pharmacy during any period of 12 consecutive months.
If a pharmacy is selling more than 5% they should be
registered as a wholesale distributor
Source found here
Subscribe to:
Posts (Atom)